Opening the book…
In culture experiments, a treatment “dose” often means its final concentration in the well. State the units and final volume. A stock concentration without its added volume does not describe what cells received. For a simple dilution, use C₁V₁ = C₂V₂, where V₂ is the final treatment volume, including the added stock.
Dimethyl sulfoxide, or DMSO, is a solvent used for many compound stocks. A stock dissolved in DMSO contributes both compound and solvent. When larger stock volumes are added at higher compound concentrations, DMSO exposure also increases unless the design corrects it. Match the final vehicle concentration across the treatment comparisons and confirm that it is suitable for the selected model and endpoint.
Worked example: matching DMSO across a concentration series
Assume a hypothetical 50 mM resveratrol stock in DMSO and a final volume of 2.00 mL per well. The planned compound concentrations are 0, 10, 25, and 50 µM. Convert the stock to 50,000 µM and the final volume to 2,000 µL.
For 25 µM: V₁ = (25 µM × 2,000 µL) ÷ 50,000 µM = 1.00 µL of stock.
The highest concentration requires 2.00 µL of stock. Match all groups to 2.00 µL total DMSO per 2,000 µL final volume. In this example, every group therefore contains 0.10% DMSO by volume.
|
Final compound |
Stock added |
Extra DMSO |
Medium* |
|
0 µM (vehicle) |
0 µL |
2.00 µL |
1,998 µL |
|
10 µM |
0.40 µL |
1.60 µL |
1,998 µL |
|
25 µM |
1.00 µL |
1.00 µL |
1,998 µL |
|
50 µM |
2.00 µL |
0 µL |
1,998 µL |
*Final volume is 2,000 µL in every group. All stock solvent is assumed to be DMSO.
These are calculation examples, not validated resveratrol treatment conditions. A planned 0.40 µL transfer is below the reliable range of many pipettes. Prepare an appropriately scaled treatment mixture or a validated working solution instead of attempting an inaccurate transfer. Recalculate both compound and solvent after any stock change. If solubility or precipitation prevents the planned exposure, revise the preparation before interpreting a response curve.
Exposure time is the interval during which cells experience the treatment. Record the actual start and end times. A 24-hour result and a 72-hour result may differ because cells have different opportunities to divide, recover, or accumulate damage. When wells are processed in sequence, plan the timing so the order does not systematically give one group longer exposure.
Specify whether treatment remains present during the entire assay, is removed before measurement, or is followed by a recovery period. A short pulse followed by several days of growth asks a different question from continuous exposure. Changing medium or washing can also remove detached cells or change the effective treatment duration.
This page titled 13.3: Concentration, Vehicle, and Exposure Time was last modified on Wed, 21 Oct 2026 01:36:14 GMT and is shared under a CC BY-NC-SA 4.0 license and was authored, remixed, and/or curated by Emalee MacKenzie.
The book could not be loaded just now.